Skip to main content
Clinical Trials/JPRN-UMIN000032431
JPRN-UMIN000032431
Completed
未知

Evaluation of safety and efficacy of inhibitor of phosphodiesterase 5 to patients with dystrophinopathy - Safety and efficacy of PDE5 inhibitor to dystrophinopathy

ational Hospital Organization Toneyama National Hospital0 sites10 target enrollmentApril 30, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
ational Hospital Organization Toneyama National Hospital
Enrollment
10
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 30, 2018
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
ational Hospital Organization Toneyama National Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • patients with 24\-hour mechanical ventilation (not include night NPPV) hypertension(Sys\>135mmHg or Diast\>90mmHg) heart failure with BNP\>100pg/ml or LVEF\<50% arrhythmia (Af,AF, VT,PSVT) diabetus mellitus

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
An evaluation of the efficacy and safety of anti-infective agent.infection
JPRN-UMIN000017224Keio University100
Active, not recruiting
Phase 1
Evaluation of the safety and efficacy of the treatment of chronic wounds in diabetic foot syndrome with the use of autologous stem cells isolated from adipose tissue - within the project: Therapeutic potential of adipose-derived stem cells, proven in clinical trials and examined in vitro - rationale for banking of well characterized cells”Diabetic foot ulcerMedDRA version: 20.0 Level: LLT Classification code 10012664 Term: Diabetic foot ulcer System Organ Class: 100000004858Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
EUCTR2016-004109-15-PLMedical University of Warsaw50
Not yet recruiting
Phase 2
VISION StudyAcute Respiratory Distress by Covid-19COVID-19SARS-CoV-2Coronavirus InfectionsSARS VirusCoronaviridae InfectionsBetacoronavirusSevere Acute Respiratory SyndromeRespiratory Tract Disease
RPCEC00000393Center for Genetic Engineering and Biotechnology (CIGB), Havana108
Active, not recruiting
Phase 3
Study on the effects of using ivermectin to prevent COVID-19 in an adult population in BrazilPrevention of COVID-19 (SARS-CoV-2 infection)Infections and Infestations
ISRCTN90437126Federal University of Pernambuco800
Not yet recruiting
Not Applicable
Dose finding study on safety and efficacy of Anti-VEDF drugs for treatment for treatment of retinopathy of prematurity
JPRN-UMIN000016657ational Center for Child Health and Development9